Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00506233 · ClinicalTrials.gov registry record
Feasibility Study of Collecting Multicenter Chronic GVHD Data
A clinical trial of Graft-Versus-Host Disease, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 13
- Enrollment target
- 2
- Study locations
NCT00506233: Completed study of Graft-Versus-Host Disease, sponsored by M.D. Anderson Cancer Center.
NCT00506233 is a study of Graft-Versus-Host Disease that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 13 participants, below the 82-participant average among 38 other Graft-Versus-Host Disease trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00506233, a study of Graft-Versus-Host Disease, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
- 2
- Study locations
Study Summary
Primary Objective: 1\. To determine the feasibility of conducting a multi-site longitudinal observational study of patients with chronic graft-versus-host disease (GVHD).
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (2)
Texas
- U.T.M.D. Anderson Cancer Center - Houston
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-08 |
What the finished NCT00506233 record still lists
NCT00506233 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 82-participant average among 38 other Graft-Versus-Host Disease trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Graft-Versus-Host Disease appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00506233 reports a single indexed study location in Texas, Washington.
Frequently Asked Questions
What is clinical trial NCT00506233 about?
NCT00506233 is a clinical study titled "Feasibility Study of Collecting Multicenter Chronic GVHD Data". Primary Objective: 1\. To determine the feasibility of conducting a multi-site longitudinal observational study of patients with chronic graft-versus-host disease (GVHD).
What is the current status of trial NCT00506233?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2006-08.
What conditions does trial NCT00506233 study?
This clinical trial studies the following conditions: Graft-Versus-Host Disease.
What interventions are being tested in trial NCT00506233?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00506233?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00506233 being conducted?
This trial has 2 study locations across Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Graft-Versus-Host Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00506233's enrollment target sits among peer trials
13 36th of 38 higher than 3 of 38 other Graft-Versus-Host Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Graft-Versus-Host Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
RECRUITING
-
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
RECRUITING · Phase 2
-
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
RECRUITING
-
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
RECRUITING · Phase 1
-
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
RECRUITING · Phase 2
-
Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia